 |
 |

Morphine-Induced Metabolic Changes in Human BrainStudies With Positron Emission Tomography and [Fluorine 18]Fluorodeoxyglucose
Edythe D. London, PhD;
Emmanuel P. M. Broussolle, MD;
Jonathan M. Links, PhD;
Dean F. Wong, MD;
Nicola G. Cascella, MD;
Robert F. Dannals, PhD;
Motoki Sano, MD, PhD;
Ronald Herning, PhD;
Frederick R. Snyder, MA;
Lillian R. Rippetoe, RN;
Thomas J. K. Toung, MD;
Jerome H. Jaffe, MD;
Henry N. Wagner, Jr, MD
Arch Gen Psychiatry. 1990;47(1):73-81.
Abstract
 |  |
Morphine sulfate effects (30 mg, intramuscularly) on cerebral glucose utilization and subjective self-reports were examined in 12 polydrug abusers by positron emission tomography and [fluorine 18]fluorodeoxyglucose in a double-blind placebocontrolled crossover study. During testing, subjects sat with eyes covered, listening to white noise and "beep" prompts. Morphine significantly reduced glucose utilization by 10% in whole brain and by about 5% to 15% in telencephalic areas and the cerebellar cortex, assuming no contribution of hypercapnia. When the contribution of Paco2 (45 minutes after morphine was administered) was partialled out, significant morphine-induced reductions persisted in whole brain and six cortical areas. Irrespective of morphine, left-greater-than-right asymmetry occurred in the temporal cortex, and an interaction between hemisphere and drug was noted in the postcentral gyrus. In most cases, effects on glucose utilization were not significantly related to measures of euphoria.
Author Affiliations
From the Addiction Research Center, National Institute on Drug Abuse (Drs London, Broussolle, Cascella, Sano, Herning, and Jaffe, Ms Rippetoe, and Mr Snyder), and Departments of Radiology (Drs Links, Wong, Dannals, and Wagner) and Anesthesiology (Dr Toung), The Johns Hopkins Medical Institutions, Baltimore, Md.
Footnotes
Accepted for publication April 7, 1989.
Presented in abstract form at the 17th Annual Meeting of the Society for Neuroscience, New Orleans, La, November 19, 1987; 140th Annual Meeting of the American Psychiatric Association, Chicago, Ill, May 9-15, 1987; and 34th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 2-5, 1987.
Reprint requests to Addiction Research Center, National Institute on Drug Abuse, PO Box 5180, Baltimore, MD 21224 (Dr London).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Transient Focal Increase in Perihematomal Glucose Metabolism After Acute Human Intracerebral Hemorrhage
Zazulia et al.
Stroke 2009;40:1638-1643.
ABSTRACT
| FULL TEXT
Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers.
Becerra et al.
Anesth. Analg. 2006;103:208-216.
ABSTRACT
| FULL TEXT
Acute Changes in Regional Cerebral 18F-FDG Kinetics in Patients with Traumatic Brain Injury
Hattori et al.
JNM 2004;45:775-783.
ABSTRACT
| FULL TEXT
Correlation of Regional Metabolic Rates of Glucose with Glasgow Coma Scale After Traumatic Brain Injury
Hattori et al.
JNM 2003;44:1709-1716.
ABSTRACT
| FULL TEXT
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
Goldstein and Volkow
Am. J. Psychiatry 2002;159:1642-1652.
ABSTRACT
| FULL TEXT
Treatment Advances for Cocaine-Induced Ischemic Stroke: Focus on Dihydropyridine-Class Calcium Channel Antagonists
Johnson et al.
Am. J. Psychiatry 2001;158:1191-1198.
ABSTRACT
| FULL TEXT
Cocaine-Induced Redoppuction of Glucose Utilization in Human Brain: A Study Using Positron Emission Tomography and [Fluorine 18]-Fluorodeoxyglucose
London et al.
Arch Gen Psychiatry 1990;47:567-574.
ABSTRACT
|